RINVOQ

Medicinal product

(Invented) name

RINVOQ

Active substance (s)

Upadacitinibas

Strength

1 mg/ml

Pharmaceutical form

geriamasis tirpalas

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

L04AF03, upadacitinib

Marketing authorisation holder

AbbVie Deutschland GmbH & Co. KG , Vokietija

Date of authorisation

2019-12-16

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

1 ml tirpalo yra:	1 ml
Upadacitinibas	1 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122364	108476	1108476	buteliukas	180 ml N1 (+buteliuko adapteris, 10 ml dozavimo švirkštas)		Receptinis	EU/1/19/1404/012	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2019-12-16	Registruotas